459pa Phase I Study to Assess the Safety and Tolerability of the Selective Akt Inhibitor Azd5363 in Japanese Patients with Advanced Solid Tumours.

@article{Esaki2014459paPI,
  title={459pa Phase I Study to Assess the Safety and Tolerability of the Selective Akt Inhibitor Azd5363 in Japanese Patients with Advanced Solid Tumours.},
  author={Taito Esaki and Takashi Seto and Fumihiko Hirai and Shuji Arita and Gouji Toyokawa and Jun Hashimoto and Yuko Tanabe and Makoto Kodaira and Kan Yonemori and Yuji Hoshino and Haruka Yamamoto and Toshio Iwata Kawata and Justin P. O. Lindemann and Kenji Tamura},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 suppl_4},
  pages={iv153}
}